Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study

Frix, Anne-Noelle; Heaney, Liam; Dahlen, Barbro; Mihaltan, Florin; Sergejeva, Svetlana; Popovic-Grle, Sanja; Sedlak, Vratislav; Lehtimaki, Lauri; Bourdin, Arnaud; Korn, Stephanie; Zervas, Eleftherios; Csoma, Zsuzsanna; Ludviksdottir, Dora; Butler, Marcus; Canonica, Giorgio; Grisle, Ineta; Bieksiene, Kristina; Ten Brinke, Anneke; Kuna, Piotr; Loureiro, Claudia; Nenasheva, Natalia; Lazic, Zorica; Skrgat, Sabina; Ramos-Barbon, David; Leuppi, Joerg; GEMİCİOĞLU, Bilun; Bossios, Apostolos; Porsbjerg, Celeste; Bel, Elisabeth; Djukanovic, Ratko; Louis, Renaud

doi:10.1183/23120541.00273-2022

Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study

Copy For Citation

Frix A., Heaney L. G., Dahlen B., Mihaltan F., Sergejeva S., Popovic-Grle S., ...More

ERJ OPEN RESEARCH, vol.8, no.4, 2022 (SCI-Expanded)

Publication Type: Article / Article
Volume: 8 Issue: 4
Publication Date: 2022
Doi Number: 10.1183/23120541.00273-2022
Journal Name: ERJ OPEN RESEARCH
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, Directory of Open Access Journals
Istanbul University Affiliated: No

Abstract

Introduction Treatment with biologics for severe asthma is informed by international and national guidelines and defined by national regulating bodies, but how these drugs are used in real-life is unknown.